BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 2008;52:3725-36. [PMID: 18625772 DOI: 10.1128/AAC.00163-08] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 2010;23:160-201. [PMID: 20065329 DOI: 10.1128/CMR.00037-09] [Cited by in Crossref: 973] [Cited by in F6Publishing: 440] [Article Influence: 81.1] [Reference Citation Analysis]
2 Yan Y, Yang H, Pan L, Sun K, Fan H, Lu Y, Shi Y. Improving the efficiency of the modified Hodge test in KPC-producing Klebsiella pneumoniae isolates by incorporating an EDTA disk. Curr Microbiol 2014;69:47-52. [PMID: 24577614 DOI: 10.1007/s00284-014-0552-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tofteland S, Naseer U, Lislevand JH, Sundsfjord A, Samuelsen O. A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving Intergenus plasmid diffusion and a persisting environmental reservoir. PLoS One 2013;8:e59015. [PMID: 23536849 DOI: 10.1371/journal.pone.0059015] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
4 Girlich D, Poirel L, Nordmann P. Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France. Antimicrob Agents Chemother 2010;54:328-32. [PMID: 19901091 DOI: 10.1128/AAC.00961-09] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
5 Richter SN, Frasson I, Bergo C, Parisi S, Cavallaro A, Palù G. Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient: first case in Europe. J Clin Microbiol 2011;49:2040-2. [PMID: 21411573 DOI: 10.1128/JCM.00133-11] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
6 Gootz TD, Lescoe MK, Dib-Hajj F, Dougherty BA, He W, Della-Latta P, Huard RC. Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother 2009;53:1998-2004. [PMID: 19258268 DOI: 10.1128/AAC.01355-08] [Cited by in Crossref: 113] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
7 Grall N, Andremont A, Armand-lefèvre L. Résistance aux carbapénèmes : vers une nouvelle impasse ? Journal des Anti-infectieux 2011;13:87-102. [DOI: 10.1016/j.antinf.2011.03.005] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ke W, Bethel CR, Papp-Wallace KM, Pagadala SR, Nottingham M, Fernandez D, Buynak JD, Bonomo RA, van den Akker F. Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226. Antimicrob Agents Chemother 2012;56:2713-8. [PMID: 22330909 DOI: 10.1128/AAC.06099-11] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
9 Smith JD, Kumarasiri M, Zhang W, Hesek D, Lee M, Toth M, Vakulenko S, Fisher JF, Mobashery S, Chen Y. Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in β-lactam resistance. Antimicrob Agents Chemother 2013;57:3137-46. [PMID: 23629710 DOI: 10.1128/AAC.00505-13] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
10 Papp-Wallace KM, Taracila M, Hornick JM, Hujer AM, Hujer KM, Distler AM, Endimiani A, Bonomo RA. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. Antimicrob Agents Chemother 2010;54:2867-77. [PMID: 20421396 DOI: 10.1128/AAC.00197-10] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
11 Piazza A, Principe L, Comandatore F, Perini M, Meroni E, Mattioni Marchetti V, Migliavacca R, Luzzaro F. Whole-Genome Sequencing Investigation of a Large Nosocomial Outbreak Caused by ST131 H30Rx KPC-Producing Escherichia coli in Italy. Antibiotics (Basel) 2021;10:718. [PMID: 34203731 DOI: 10.3390/antibiotics10060718] [Reference Citation Analysis]
12 Shurina BA, Page RC. Influence of substrates and inhibitors on the structure of Klebsiella pneumoniae carbapenemase-2. Exp Biol Med (Maywood) 2019;244:1596-604. [PMID: 31161945 DOI: 10.1177/1535370219854322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Ryu BH, Ngo TD, Yoo W, Lee S, Kim BY, Lee E, Kim KK, Kim TD. Biochemical and Structural Analysis of a Novel Esterase from Caulobacter crescentus related to Penicillin-Binding Protein (PBP). Sci Rep 2016;6:37978. [PMID: 27905486 DOI: 10.1038/srep37978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
14 Naas T, Dortet L, Iorga BI. Structural and Functional Aspects of Class A Carbapenemases. Curr Drug Targets 2016;17:1006-28. [PMID: 26960341 DOI: 10.2174/1389450117666160310144501] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 12.6] [Reference Citation Analysis]
15 Tsakris A, Voulgari E, Poulou A, Kimouli M, Pournaras S, Ranellou K, Kosmopoulou O, Petropoulou D. In vivo acquisition of a plasmid-mediated bla(KPC-2) gene among clonal isolates of Serratia marcescens. J Clin Microbiol. 2010;48:2546-2549. [PMID: 20463153 DOI: 10.1128/jcm.00264-10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
16 Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785-796. [PMID: 23969216 DOI: 10.1016/s1473-3099(13)70190-7] [Cited by in Crossref: 920] [Cited by in F6Publishing: 498] [Article Influence: 102.2] [Reference Citation Analysis]
17 Krishnan NP, Nguyen NQ, Papp-Wallace KM, Bonomo RA, van den Akker F. Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study. PLoS One 2015;10:e0136813. [PMID: 26340563 DOI: 10.1371/journal.pone.0136813] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
18 Lv R, Guo J, Yan Y, Chen R, Xiao L, Wang M, Fang N, Fang C, Cui Y, Yang R, Song Y. Characterization of a novel class A carbapenemase PAD-1 from Paramesorhizobium desertii A-3-ET, a strain highly resistant to β-lactam antibiotics. Sci Rep 2017;7:8370. [PMID: 28827656 DOI: 10.1038/s41598-017-07841-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Xu T, Ying J, Yao X, Song Y, Ma P, Bao B, Jiang W, Wu X, Tou H, Li P, Ren P, Fei J, Yang L, Liu Q, Xu Z, Zhou T, Ni L, Bao Q. Identification and characterization of two novel bla(KLUC) resistance genes through large-scale resistance plasmids sequencing. PLoS One 2012;7:e47197. [PMID: 23056610 DOI: 10.1371/journal.pone.0047197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
20 Lamoureaux TL, Vakulenko V, Toth M, Frase H, Vakulenko SB. A novel extended-spectrum β-lactamase, SGM-1, from an environmental isolate of Sphingobium sp. Antimicrob Agents Chemother 2013;57:3783-8. [PMID: 23716045 DOI: 10.1128/AAC.00808-13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Snyder GM, O'Fallon E, D'Agata EM. Co-colonization with multiple different species of multidrug-resistant gram-negative bacteria. Am J Infect Control 2011;39:506-10. [PMID: 21492962 DOI: 10.1016/j.ajic.2010.09.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
22 Pemberton OA, Zhang X, Chen Y. Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2). J Med Chem 2017;60:3525-30. [PMID: 28388065 DOI: 10.1021/acs.jmedchem.7b00158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
23 Li P, Shen K, Zhang Y, Ying J, Zhu T, Liu Y, Xu L, Lin C, Zhang K, Li P, Lu J, Li K, Yi H, Bao Q, Xu T. Characterization of a Novel blaKLUC Variant With Reduced β-Lactam Resistance From an IncA/C Group Plasmid in a Clinical Klebsiella pneumoniae Isolate. Front Microbiol 2018;9:1908. [PMID: 30158920 DOI: 10.3389/fmicb.2018.01908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Tooke CL, Hinchliffe P, Lang PA, Mulholland AJ, Brem J, Schofield CJ, Spencer J. Molecular Basis of Class A β-Lactamase Inhibition by Relebactam. Antimicrob Agents Chemother 2019;63:e00564-19. [PMID: 31383664 DOI: 10.1128/AAC.00564-19] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
25 Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrob Agents Chemother 2010;54:2687-91. [PMID: 20231393 DOI: 10.1128/AAC.01359-09] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
26 Sahuquillo-Arce JM, Hernández-Cabezas A, Yarad-Auad F, Ibáñez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: A worldwide threat to antimicrobial therapy. World J Pharmacol 2015; 4(1): 75-95 [DOI: 10.5497/wjp.v4.i1.75] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Alsenani TA, Viviani SL, Kumar V, Taracila MA, Bethel CR, Barnes MD, Papp-Wallace KM, Shields RK, Nguyen MH, Clancy CJ, Bonomo RA, van den Akker F. Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam. Antimicrob Agents Chemother 2022;:e0241421. [PMID: 35341315 DOI: 10.1128/aac.02414-21] [Reference Citation Analysis]
28 Stachyra T, Levasseur P, Péchereau MC, Girard AM, Claudon M, Miossec C, Black MT. In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother 2009;64:326-9. [PMID: 19493866 DOI: 10.1093/jac/dkp197] [Cited by in Crossref: 127] [Cited by in F6Publishing: 122] [Article Influence: 9.8] [Reference Citation Analysis]
29 Nikolaidis I, Favini-Stabile S, Dessen A. Resistance to antibiotics targeted to the bacterial cell wall. Protein Sci 2014;23:243-59. [PMID: 24375653 DOI: 10.1002/pro.2414] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]
30 Levitt PS, Papp-Wallace KM, Taracila MA, Hujer AM, Winkler ML, Smith KM, Xu Y, Harris ME, Bonomo RA. Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis. J Biol Chem 2012;287:31783-93. [PMID: 22843686 DOI: 10.1074/jbc.M112.348540] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
31 Papp-Wallace KM, Taracila M, Wallace CJ, Hujer KM, Bethel CR, Hornick JM, Bonomo RA. Elucidating the role of Trp105 in the KPC-2 β-lactamase. Protein Sci 2010;19:1714-27. [PMID: 20662006 DOI: 10.1002/pro.454] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
32 Pozzi C, De Luca F, Benvenuti M, Poirel L, Nordmann P, Rossolini GM, Mangani S, Docquier JD. Crystal Structure of the Pseudomonas aeruginosa BEL-1 Extended-Spectrum β-Lactamase and Its Complexes with Moxalactam and Imipenem. Antimicrob Agents Chemother 2016;60:7189-99. [PMID: 27671060 DOI: 10.1128/AAC.00936-16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Zhao WH, Hu ZQ. Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria. Crit Rev Microbiol 2013;39:79-101. [PMID: 22697133 DOI: 10.3109/1040841X.2012.691460] [Cited by in Crossref: 159] [Cited by in F6Publishing: 78] [Article Influence: 15.9] [Reference Citation Analysis]
34 Furey IM, Mehta SC, Sankaran B, Hu L, Prasad BVV, Palzkill T. Local interactions with the Glu166 base and the conformation of an active site loop play key roles in carbapenem hydrolysis by the KPC-2 β-lactamase. J Biol Chem 2021;296:100799. [PMID: 34022225 DOI: 10.1016/j.jbc.2021.100799] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Jeong JH, Kim YS, Rojviriya C, Ha SC, Kang BS, Kim YG. Crystal structures of bifunctional penicillin-binding protein 4 from Listeria monocytogenes. Antimicrob Agents Chemother 2013;57:3507-12. [PMID: 23669378 DOI: 10.1128/AAC.00144-13] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
36 Mosca A, Miragliotta L, Del Prete R, Tzakis G, Dalfino L, Bruno F, Pagani L, Migliavacca R, Piazza A, Miragliotta G. Rapid and sensitive detection of bla KPC gene in clinical isolates of Klebsiella pneumoniae by a molecular real-time assay. Springerplus 2013;2:31. [PMID: 23450269 DOI: 10.1186/2193-1801-2-31] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
37 Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011;55:4943-60. [PMID: 21859938 DOI: 10.1128/AAC.00296-11] [Cited by in Crossref: 624] [Cited by in F6Publishing: 297] [Article Influence: 56.7] [Reference Citation Analysis]
38 Galani I, Panagea T, Chryssouli Z, Giamarellou H, Souli M. In vivo transmission of a plasmid containing the KPC-2 gene in a single patient. J Glob Antimicrob Resist 2013;1:35-8. [PMID: 27873604 DOI: 10.1016/j.jgar.2013.02.003] [Reference Citation Analysis]
39 Nichols DA, Renslo AR, Chen Y. Fragment-based inhibitor discovery against β-lactamase. Future Med Chem 2014;6:413-27. [PMID: 24635522 DOI: 10.4155/fmc.14.10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
40 Agarwal V, Yadav TC, Tiwari A, Varadwaj P. Detailed investigation of catalytically important residues of class A β-lactamase. J Biomol Struct Dyn 2022;:1-28. [PMID: 34986744 DOI: 10.1080/07391102.2021.2023645] [Reference Citation Analysis]
41 Egorov A, Rubtsova M, Grigorenko V, Uporov I, Veselovsky A. The Role of the Ω-Loop in Regulation of the Catalytic Activity of TEM-Type β-Lactamases. Biomolecules 2019;9:E854. [PMID: 31835662 DOI: 10.3390/biom9120854] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
42 Li Y, Luo L, Xiao Z, Wang G, Li C, Zhang Z, Zhou Y, Zhang L. Characterization of a Carbapenem-Resistant Kluyvera Cryocrescens Isolate Carrying Blandm-1 from Hospital Sewage. Antibiotics (Basel) 2019;8:E149. [PMID: 31527387 DOI: 10.3390/antibiotics8030149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Tsakris A, Poulou A, Themeli-Digalaki K, Voulgari E, Pittaras T, Sofianou D, Pournaras S, Petropoulou D. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae. J Clin Microbiol 2009;47:3420-6. [PMID: 19726597 DOI: 10.1128/JCM.01314-09] [Cited by in Crossref: 50] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
44 Docquier JD, Benvenuti M, Calderone V, Rossolini GM, Mangani S. Structure of the extended-spectrum β-lactamase TEM-72 inhibited by citrate. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011;67:303-6. [PMID: 21393831 DOI: 10.1107/S1744309110054680] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Margate E, Magalhães V, Fehlberg LC, Gales AC, Lopes AC. KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL. Rev Inst Med Trop Sao Paulo 2015;57:359-60. [PMID: 26422164 DOI: 10.1590/S0036-46652015000400016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]